| Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease M Cavazzana-Calvo, S Hacein-Bey, GS Basile, F Gross, E Yvon, ... Science 288 (5466), 669-672, 2000 | 3497 | 2000 |
| Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy S Hacein-Bey-Abina, F Le Deist, F Carlier, C Bouneaud, C Hue, ... New england journal of medicine 346 (16), 1185-1193, 2002 | 1449 | 2002 |
| Vector integration is nonrandom and clustered and influences the fate of lymphopoiesis in SCID-X1 gene therapy A Deichmann, S Hacein-Bey-Abina, M Schmidt, A Garrigue, MH Brugman, ... The Journal of clinical investigation 117 (8), 2225-2232, 2007 | 294 | 2007 |
| Hyperfunctional C3 convertase leads to complement deposition on endothelial cells and contributes to atypical hemolytic uremic syndrome LT Roumenina, M Jablonski, C Hue, J Blouin, JD Dimitrov, ... Blood, The Journal of the American Society of Hematology 114 (13), 2837-2845, 2009 | 193 | 2009 |
| A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function LT Roumenina, M Frimat, EC Miller, F Provot, MA Dragon-Durey, ... Blood, The Journal of the American Society of Hematology 119 (18), 4182-4191, 2012 | 157 | 2012 |
| Failure of SCID-X1 gene therapy in older patients AJ Thrasher, S Hacein-Bey-Abina, HB Gaspar, S Blanche, EG Davies, ... Blood 105 (11), 4255-4257, 2005 | 143 | 2005 |
| Mapping interactions between complement C3 and regulators using mutations in atypical hemolytic uremic syndrome EC Schramm, LT Roumenina, T Rybkine, S Chauvet, P Vieira-Martins, ... Blood, The Journal of the American Society of Hematology 125 (15), 2359-2369, 2015 | 130 | 2015 |
| Complement factor B mutations in atypical hemolytic uremic syndrome—disease-relevant or benign? MC Marinozzi, L Vergoz, T Rybkine, S Ngo, S Bettoni, A Pashov, M Cayla, ... Journal of the American Society of Nephrology 25 (9), 2053-2065, 2014 | 114 | 2014 |
| Microbial-host co-metabolites are prodromal markers predicting phenotypic heterogeneity in behavior, obesity, and impaired glucose tolerance ME Dumas, AR Rothwell, L Hoyles, T Aranias, J Chilloux, S Calderari, ... Cell Reports 20 (1), 136-148, 2017 | 89 | 2017 |
| Clonal evidence for the transduction of CD34+ cells with lymphomyeloid differentiation potential and self-renewal capacity in the SCID-X1 gene therapy trial M Schmidt, S Hacein-Bey-Abina, M Wissler, F Carlier, A Lim, C Prinz, ... Blood 105 (7), 2699-2706, 2005 | 86 | 2005 |
| Long-term immune reconstitution in RAG-1-deficient mice treated by retroviral gene therapy: a balance between efficiency and toxicity C Lagresle-Peyrou, F Yates, M Malassis-Séris, C Hue, E Morillon, ... Blood 107 (1), 63-72, 2006 | 75 | 2006 |
| A MEI1 homozygous missense mutation associated with meiotic arrest in a consanguineous family M Ben Khelifa, F Ghieh, R Boudjenah, C Hue, D Fauvert, R Dard, ... Human Reproduction 33 (6), 1034-1037, 2018 | 54 | 2018 |
| Nutrigenomics of high fat diet induced obesity in mice suggests relationships between susceptibility to fatty liver disease and the proteasome H Waller-Evans, C Hue, J Fearnside, AR Rothwell, HE Lockstone, ... PLoS One 8 (12), e82825, 2013 | 53 | 2013 |
| Restoration of human B-cell differentiation into NOD-SCID mice engrafted with gene-corrected CD34+ cells isolated from Artemis or RAG1-deficient patients C Lagresle-Peyrou, F Benjelloun, C Hue, I Andre-Schmutz, D Bonhomme, ... Molecular Therapy 16 (2), 396-403, 2008 | 46 | 2008 |
| Optimization of retroviral gene transfer protocol to maintain the lymphoid potential of progenitor cells S Hacein-Bey, F Gross, P Nusbaum, C Hue, Y Hamel, A Fischer, ... Human gene therapy 12 (3), 291-301, 2001 | 44 | 2001 |
| Dissecting the phenotypic and functional heterogeneity of mouse inflammatory osteoclasts by the expression of Cx3cr1 MB Madel, L Ibanez, T Ciucci, J Halper, M Rouleau, A Boutin, C Hue, ... Elife 9, e54493, 2020 | 42 | 2020 |
| Eculizumab in an anephric patient with atypical haemolytic uraemic syndrome and advanced vascular lesions ZD Békássy, AC Kristoffersson, M Cronqvist, LT Roumenina, T Rybkine, ... Nephrology Dialysis Transplantation 28 (11), 2899-2907, 2013 | 33 | 2013 |
| Expression of coagulation factor IX in a haematopoietic cell line MH Rodriguez, N Enjolras, JL Plantier, M Réa, M Leboeuf, G Uzan, ... Thrombosis and haemostasis 87 (03), 366-373, 2002 | 31 | 2002 |
| Adaptive expression of microRNA-125a in adipose tissue in response to obesity in mice and men MR Diawara, C Hue, SP Wilder, N Venteclef, J Aron-Wisnewsky, J Scott, ... PLoS One 9 (3), e91375, 2014 | 30 | 2014 |
| Modulatory role of the anti-apoptotic protein kinase CK2 in the sub-cellular localization of Fas associated death domain protein (FADD) V Vilmont, O Filhol, AM Hesse, Y Couté, C Hue, L Rémy-Tourneur, ... Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1853 (11), 2885-2896, 2015 | 25 | 2015 |
Frank YatesSup'BiotechVerified email at supbiotech.fr
Frank YatesSup'BiotechVerified email at supbiotech.fr